Company Profile
Neuronetics Stock Price, News & Catalysts
- Ticker:
- STIM
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
3.21 USD (+0.63%)
Close
Last updated: August 12, 2026
109M USD
Market cap
Why the stock is moving
Following the latest company update, “Neuronetics Reports Second Quarter 2026 Financial and Operating Results”, STIM closed up 47.0% at $3.19 on Aug 11, 2026. The move occurred in the trading session associated with this earnings update.
Company overview
Neurohealth Technology and Care Delivery
Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy.
NeuroStar Advanced Therapy
NeuroStar uses transcranial magnetic stimulation to treat major depressive disorder without surgery or systemic medication. The platform is sold to healthcare providers together with recurring treatment-session consumables and services.
Greenbrook Clinic Network
Through Greenbrook treatment centers, Neuronetics directly provides NeuroStar therapy and SPRAVATO for treatment-resistant depression. The integrated model gives the company exposure to both medical-device utilization and the economics of operating behavioral-health treatment sites.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Neuronetics (STIM)?
Neuronetics (STIM) most recently closed at 3.21 USD, a +0.63% move versus the previous session.
What is the market cap of Neuronetics (STIM)?
Neuronetics currently has a market capitalization of 109M USD on BioPharmSignal.
What does Neuronetics do?
Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses transcranial magnetic...
On which exchange is STIM stock listed?
Neuronetics (STIM) is associated with NASDAQ, United States, Biopharma.
What is Neurohealth?
Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders.
Which conditions is Neuronetics targeting with Neurohealth?
Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses transcranial magnetic...
What is Technology?
Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders.
What is Care?
Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders.